SEC Company Response from ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE) — Nov 19, 2020
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: Nov. 19, 2020 · CIK: 0001131343 · Accession: 0001213900-20-038189
AI Filing Summary & Sentiment
File numbers found in text: 333-250076
Show Raw Text
CORRESP
1
filename1.htm
Alterity Therapeutics Ltd.
Level 3, 460 Bourke Street, Melbourne, Victoria 3000 Australia
November 18,
2020
VIA EDGAR
Deanna Virginio, Esq.
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Alterity Therapeutics Ltd.
Registration Statement on Form F-3
File No. 333-250076
Dear Ms. Virginio:
The undersigned, on
behalf of Alterity Therapeutics Ltd. (“Alterity”), issuer of the securities covered by the above-referenced Registration
Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities
and Exchange Commission at 4:00 p.m. Washington, D.C. time, on Monday, November 23, 2020, or as soon thereafter as possible.
Management of Alterity
is aware of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the
disposition of the securities covered by the above-referenced Registration Statement.
Thank you very much
for your courtesy in this matter.
Very truly yours,
/s/Kathryn Andrews
Kathryn Andrews
Chief Financial Officer